Search for: "OR Specific, Inc."
Results 4401 - 4420
of 37,641
Sorted by Relevance
|
Sort by Date
2 Aug 2013, 5:30 am
©2013 Amaxx Risk Solutions, Inc. [read post]
24 Jun 2018, 10:50 am
National Bellas Hess, Inc. v. [read post]
Applying Preclusion Based on TTAB Decision, Ohio District Court Denies Non-Infringement Counterclaim
5 Jul 2017, 3:19 am
Buzz Seating Inc. v. [read post]
19 Jan 2016, 3:52 am
See Safer Inc. v. [read post]
18 May 2023, 6:57 am
Broadleaf Results, Inc. and Conduent State and Local Solutions, Inc., Civil Action No. 1:22-cv-4557-PKC-LB), revolves around an employee who was terminated after requesting an accommodation for her hearing-related condition. [read post]
28 Feb 2013, 6:01 am
Genentech, also known as "Genetic Engineering Technology, Inc." is a wholly owned subsidiary of F. [read post]
9 May 2017, 5:00 am
Companies in addition to Apple that filed conflict minerals reports include: Sphere 3D Corp.; Quantum Corporation; Amerityre Corporation; O2 Micro International Limited; Jason Industries, Inc.; Babcock & Wilcox Enterprises, Inc.; and KEMET Corporation. [read post]
4 Sep 2018, 5:00 pm
Wal-Mart Stores, Inc. v. [read post]
1 Mar 2013, 3:12 pm
Scis., Inc. v. [read post]
10 Jul 2013, 5:30 am
©2013 Amaxx Risk Solutions, Inc. [read post]
14 Jul 2014, 2:45 pm
Prods., Inc., 334 F.3d 1274, 1279 (Fed. [read post]
4 Jan 2013, 11:51 am
Plumtree Software, Inc., 417 F.3d 1342, 1347 (Fed. [read post]
7 Jun 2016, 5:22 pm
” Medtronic Sofamor Danek USA, Inc. v.NuVasive, Inc., 136 S. [read post]
25 May 2018, 8:23 am
Cir. 1990) (finding party “cannot now expand thescope of its specifically limited notice of appeal”). [read post]
18 Jun 2018, 5:18 am
In re El Galan, Inc., Serial No. 86961428 (February 1, 2018) [not precedential]: El Galan, Inc. [read post]
21 Feb 2017, 4:35 am
In Eastex, Inc. v. [read post]
21 Feb 2017, 4:35 am
In Eastex, Inc. v. [read post]
11 Oct 2017, 1:14 pm
(“SEG”) and Black Gold Resources, Inc. [read post]
16 Dec 2013, 5:00 am
American Petroleum and Transport, Inc. v. [read post]
9 Feb 2009, 5:10 am
However, if such claims are based solely on allegations that the respective defendants violated the FDCA, then the claims are preempted.The case involves a group of seven health benefit plans accusing Amgen, Inc., DaVita, Inc. and Fresenius Medical Care Holdings, Inc. of unlawfully promoting the off-label use of two drugs, Epogen and Aranesp (collectively, “EPO”), between 2002 and 2007. [read post]
